Quality control and quality assessment of coagulation tests in Japan.
Southeast Asian J Trop Med Public Health
;
2002 ; 33 Suppl 2(): 99-103
Article
in English
| IMSEAR
| ID: sea-35711
ABSTRACT
We have used prothrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen (Fbg), and fibronogen/fibrin degradation products (FDP) as screening coagulation tests, and antithrombin III (AT III), plasminogen (Plg), alpha2-plasmin inhibitor (alpha2-PI), protein C (PC), thrombin-AT III complex (TAT), plasmin-alpha2-PI complex (PIC), and D-dimer as special coagulation tests. We report the present condition of internal and external quality control for these coagulation tests in Japan. We made a summary report of internal quality control of some coagulation tests in Division of Hematology Laboratory, Department of Laboratory Medicine, Hokkaido University Hospital. The repeatability and reproducibility of screening tests were good, but those of special tests were partly adequate. We have participated in some external quality control surveillance including Japan Medical Association (JMA), Japanese Association of Laboratory Medical Technologists (JALMT), College of American Pathologists (CAP), and some commercial quality control surveillance. We also reported the results of some external quality control surveillance.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Quality Assurance, Health Care
/
Quality Control
/
Blood Coagulation Tests
/
Humans
/
Reproducibility of Results
/
Japan
/
Laboratories
Country/Region as subject:
Asia
Language:
English
Journal:
Southeast Asian J Trop Med Public Health
Year:
2002
Type:
Article
Similar
MEDLINE
...
LILACS
LIS